Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03268655 · ClinicalTrials.gov registry record · NA
Ginger and Gut Microbiome (GINGER)
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT03268655 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 68 participants.
The verdict
NCT03268655, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
Estimate the impact of a 6-week daily intake of 2000 mg of ginger extract on the composition of the gut microbiome using a randomized placebo-controlled double-blinded design, i.e. examine the change of microbiome over time within and between the subjects..
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Ginger extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2018-11-14 |
| Est. Completion | 2020-06-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03268655
The ClinicalTrials.gov registry entry for NCT03268655 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03268655 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03268655 about?
NCT03268655 is a clinical study titled "Ginger and Gut Microbiome (GINGER)". Estimate the impact of a 6-week daily intake of 2000 mg of ginger extract on the composition of the gut microbiome using a randomized placebo-controlled double-blinded design, i.e. examine the change of microbiome over time within and between the subjects..
What is the current status of trial NCT03268655?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2018-11-14. Estimated completion is 2020-06-26.
What interventions are being tested in trial NCT03268655?
The interventions under investigation include: Placebo (OTHER), Ginger extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03268655?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.